Healthy Returns: What to know about the FDA’s plan to speed up some drug reviews
The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to-consumer offering.
Healthy scepticism is needed because flaw is that large language models remain prone to casually making things up
From helping consultants diagnose cancer, to aiding teachers in drawing up lesson plan…